Is Anodyne ® Therapy a covered treatment by Highmark Medicare Services for treatment of diabetic peripheral neuropathy?
According to Highmark Medicare Services LCD 06-032, effective 2-15-06. There has been insufficient evidence in the peer-reviewed, evidence-based literature to support providing coverage for this service. At this time, Anodyne® therapy for the treatment of diabetic peripheral neuropathy is not recognized as a standard of care, therefore is considered experimental and investigational, and not reimbursable by Medicare. There is currently no circumstance for which Medicare covers Anodyne® Therapy.
Related Questions
- Is Hyperbaric Oxygen Therapy (HBO) covered as a first-line therapy for treatment of diabetic wounds of the lower extremities?
- Is Anodyne ® Therapy a covered treatment by Highmark Medicare Services for treatment of diabetic peripheral neuropathy?
- Is Anodyne Therapy The Answer For Peripheral Neuropathy?
